ALUNNO, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 2.742
AS - Asia 1.426
EU - Europa 1.337
SA - Sud America 232
Continente sconosciuto - Info sul continente non disponibili 68
AF - Africa 25
OC - Oceania 4
Totale 5.834
Nazione #
US - Stati Uniti d'America 2.685
SG - Singapore 631
RU - Federazione Russa 315
CN - Cina 280
IE - Irlanda 274
BR - Brasile 198
HK - Hong Kong 145
IT - Italia 142
DE - Germania 131
TR - Turchia 130
VN - Vietnam 126
SE - Svezia 105
UA - Ucraina 86
GB - Regno Unito 64
NL - Olanda 60
FR - Francia 54
FI - Finlandia 39
CA - Canada 37
IN - India 28
JP - Giappone 14
PL - Polonia 13
BD - Bangladesh 12
AR - Argentina 11
BE - Belgio 11
ID - Indonesia 10
IQ - Iraq 10
ES - Italia 8
PK - Pakistan 7
CO - Colombia 6
MX - Messico 6
EC - Ecuador 5
MY - Malesia 5
NP - Nepal 5
ZA - Sudafrica 5
AU - Australia 4
CH - Svizzera 4
DZ - Algeria 4
EU - Europa 4
HN - Honduras 4
MA - Marocco 4
PH - Filippine 4
RO - Romania 4
TH - Thailandia 4
TN - Tunisia 4
AT - Austria 3
CL - Cile 3
DK - Danimarca 3
LT - Lituania 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
PR - Porto Rico 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
DM - Dominica 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
IM - Isola di Man 1
KE - Kenya 1
KR - Corea 1
LU - Lussemburgo 1
LV - Lettonia 1
NE - Niger 1
NG - Nigeria 1
NI - Nicaragua 1
PE - Perù 1
PY - Paraguay 1
SA - Arabia Saudita 1
SM - San Marino 1
SN - Senegal 1
SV - El Salvador 1
TW - Taiwan 1
Totale 5.770
Città #
Jacksonville 326
Singapore 323
San Jose 320
Chandler 315
Dublin 266
Dallas 207
Ashburn 181
Hong Kong 144
Santa Clara 130
Boardman 105
New York 79
Izmir 78
Council Bluffs 69
The Dalles 64
Moscow 60
Amsterdam 54
Beijing 54
Wilmington 54
Nanjing 53
Lawrence 49
Princeton 49
Los Angeles 45
Ho Chi Minh City 44
San Mateo 34
Ann Arbor 27
Hanoi 27
Milan 25
L'aquila 22
Lauterbourg 22
Frankfurt am Main 21
São Paulo 21
Nanchang 20
Munich 16
Pescara 16
Seattle 16
Des Moines 15
Hefei 15
Rome 15
Shanghai 15
Dearborn 14
Toronto 14
Columbus 13
Chennai 11
Woodbridge 11
Helsinki 10
Montreal 10
Verona 10
Warsaw 10
Brooklyn 9
Jiaxing 9
Norwalk 9
Orem 9
Tianjin 9
Tokyo 9
Chicago 8
Brussels 7
Hebei 7
Jakarta 7
London 7
Mountain View 7
Rio de Janeiro 7
San Francisco 7
Da Nang 6
Lappeenranta 6
Manchester 6
Philadelphia 6
Atlanta 5
Brasília 5
Buffalo 5
Haiphong 5
Phoenix 5
Pune 5
Zhengzhou 5
Baghdad 4
Bangkok 4
Belo Horizonte 4
Berlin 4
Bogotá 4
Bremen 4
Changsha 4
Denver 4
Dong Ket 4
Falkenstein 4
Hangzhou 4
Hải Dương 4
Las Vegas 4
Leuven 4
Milwaukee 4
Naples 4
Ningbo 4
Nuremberg 4
Shenyang 4
Stockholm 4
Ankara 3
Bragança Paulista 3
Bắc Ninh 3
Cape Town 3
Cedar Knolls 3
Charleston 3
Charlotte 3
Totale 3.770
Nome #
12-MONTH OUTCOMES IN OVERWEIGHT/OBESE USERS WITH MENTAL DISORDERS FOLLOWING A MULTI-ELEMENT TREATMENT INCLUDING DIET, PHYSICAL ACTIVITY, AND POSITIVE THINKING: THE REAL-WORLD ‘AN APPLE A DAY’ CONTROLLED TRIAL 183
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 163
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: Results of a large multicentre study 144
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 137
Pericarditis after sars‐cov‐2 infection: Another pebble in the mosaic of long covid? 137
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives. 135
SpA plus IBD or IBD plus SpA: Does commutative property apply? 132
The Need to Target Mucosa-Associated Lymphoid Tissue for Preventing Lymphoma in Rheumatoid Factor-Positive Patients with Sjögren's Syndrome: Comment on the Article by Nocturne et al 129
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 125
Diet in rheumatoid arthritis versus systemic lupus erythematosus: Any differences? 118
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 116
Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis 116
Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flares 114
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 113
Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units 113
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 110
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 110
EFFICACY AND SAFETY OF RITUXIMAB ORIGINATOR AND BIOSIMILAR IN PRIMARY SJOGREN'S SYNDROME IN A REAL-LIFE SETTING 110
Common Features in Lymphoproliferative Complications in the Course of Primary Sjo‥gren’s Syndrome: Results From a Multicenter Cohort of 1170 Patients 109
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: A pilot study 109
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome 109
Interferon gamma-inducible protein 16 in primary Sjögren's syndrome: a novel player in disease pathogenesis? 108
Unmasking the pathogenic role of il-17 axis in primary sj¨ogren’s syndrome: A new era for therapeutic targeting? 108
CLINICAL AND IMAGING FEATURES OF ARTICULAR MANIFESTATIONS IN PRIMARY SJOGREN'S SYNDROME: SIMILARITIES AND DIFFERENCES ACCORDING TO THE TIME OF ONSET 108
Adherence to the Mediterranean diet and the impact on clinical features in primary Sjögren's syndrome 107
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry 106
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 106
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 106
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. 104
CD4(-)CD8(-) T-cells in primary Sjögren's syndrome: association with the extent of glandular involvement. 102
Rischio cardiovascolare nei pazienti affetti da malattie infiammatorie croniche: valutazione della relazione tra meccanismi immunologici, profilo metabolico e stile di vita 101
Serological biomarkers of b-cell lymphoproliferative disorders in patients with primary sjögren’s syndrome: retrospective study in a large italian cohort 99
The kaleidoscope of neurological manifestations in primary Sjögren's syndrome 99
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 95
Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis 92
Histopathology of salivary glands 92
Post-Translational Modifications of Proteins: Novel Insights in the Autoimmune Response in Rheumatoid Arthritis 92
Electrocardiographic Abnormalities in Hospitalized Patients with COVID-19 and the Associations with Clinical Outcome 91
Rituximab in primary Sjögren's syndrome: a ten-year journey 91
Lymphoma and Lymphomagenesis in Primary Sjögren's Syndrome 91
Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren's syndrome treated with rituximab: a possible role for glandular BAFF 90
The Interplay between Cardiovascular Risk, Cardiovascular Events, and Disease Activity in Primary Sjögren’s Syndrome: Is Uric Acid the Missing Link? 89
Characteristics of primary sjögren’s syndrome (PSS) patients with cryoglobulinemia in a large cohort of patients, and differences between hypergammaglobulinemic and cryoglobulinemic vasculitis in PSS 88
The impact of fibromyalgia in spondyloarthritis: From classification criteria to outcome measures 87
The role of T helper 17 cell subsets in Sjögren's syndrome: similarities and differences between mouse model and humans. 86
IL-17 PRODUCING DOUBLE NEGATIVE (DN) T CELL PHENOTYPE AND FUNCTION IN PRIMARY SJÖGREN'S SYNDROME 86
Thymic Stromal Lymphopoietin (TSLP) as a Biomarker of Primary Sjogren's Syndrome (pSS) and Related Lymphoma: Results in Independent Cohorts 84
The Impact of SARS-CoV-2 Outbreak on Primary Sjögren's Syndrome: An Italian Experience 79
PREVALENCE AND PREDICTIVE ROLE OF TRADITIONAL CARDIOVASCULAR RISK FACTORS IN A COHORT OF SJÖGREN'S SYNDROME PATIENTS 75
THU0681 Baseline ESSDAI/DAS scores in 8061 patients with primary sjÖgren syndrome: characterization of systemic disease 74
Celiac Disease Prevalence is Increased in Primary Sjögren's Syndrome and Diffuse Systemic Sclerosis: Lessons from a Large Multi-Center Study 71
OP0044 Antibodies anti-saccharomyces cerevisiae in primary sjÖgren's syndrome: prevalence, clinical associations and possible cross-reactivity with disease specific autoantigens 71
SAT0641 Performance and agreement of different operators and histological techniques for the assessment of germinal centres in minor salivary glands in primary sjÖgren’s syndrome 69
The challenge to interpret conflicting results and the need of a univocal definition for germinal centres in primary Sjögren's syndrome 67
Different clinical presentations of primary Sjögren's syndrome: Not only a matter of age. Comment on: “Elderly-onset primary Sjögren's syndrome focused on clinical and salivary gland ultrasonographic features by Lee et al. Joint Bone Spine. 2021;88:105132” 65
Neurological Involvement in a Cohort of Primary Sjogren's Syndrome Patients: Results of a Multicenter Italian Study 63
A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 60
Totale 5.834
Categoria #
all - tutte 26.613
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.613


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022253 0 11 38 24 8 10 2 15 24 8 24 89
2022/2023810 69 44 17 89 86 96 0 46 318 8 29 8
2023/2024232 23 13 11 18 24 80 1 13 1 14 5 29
2024/20251.121 38 20 99 62 104 99 202 78 221 44 90 64
2025/20262.111 110 195 148 190 189 136 378 75 268 263 128 31
2026/2027173 68 105 0 0 0 0 0 0 0 0 0 0
Totale 5.834